Nephros Inc (NEPH) Q3 2024 Earnings Call Highlights: First Profitable Quarter and Strategic ... [Yahoo! Finance]
Nephros, Inc. (NEPH)
NASDAQ:AMEX Investor Relations:
nephros.com/investor-relations
Company Research
Source: Yahoo! Finance
Gross Margin: 61%, up from 59% in Q3 2023. Adjusted EBITDA: $295,000, a significant improvement from $11,000 in Q3 2023. SG&A Expenses: Reduced to $1.7 million from $2.1 million in Q3 2023. Cash and Cash Equivalents: $2.5 million as of September 30, 2024, down from $4.3 million at the end of 2023. Net Loss (Nine Months Ending September 30, 2024): Decreased 70% to $275,000 from $921,000 in the prior year period. Sales (Nine Months Ending September 30, 2024): Declined by 6% to $10.3 million from $11 million in the prior year period. Warning! GuruFocus has detected 2 Warning Signs with NEPH. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Nephros Inc ( NASDAQ:NEPH ) achieved its first profitable quarter since inception, reporting a net income of $0.2 million compared to a net loss of $0.2 million in Q3 of last year. Gross margin improved to 61% from 59% in Q3 2023, reflecting better t
Show less
Read more
Impact Snapshot
Event Time:
NEPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEPH alerts
High impacting Nephros, Inc. news events
Weekly update
A roundup of the hottest topics
NEPH
News
- Nephros, Inc. (NASDAQ: NEPH) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.MarketBeat
- Nephros Announces Financial Results for Quarter Ended September 30, 2024 [Yahoo! Finance]Yahoo! Finance
- Nephros Announces Financial Results for Quarter Ended September 30, 2024GlobeNewswire
- What To Expect From Nephros Inc (NEPH) Q3 2024 Earnings [Yahoo! Finance]Yahoo! Finance
- Nephros Schedules Third Quarter 2024 Financial Results Conference CallGlobeNewswire
NEPH
Sec Filings
- 11/14/24 - Form 10-Q
- 11/13/24 - Form 8-K
- 8/26/24 - Form 8-K
- NEPH's page on the SEC website